rs2230589

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP7BS2_SupportingBA1

This summary comes from the ClinGen Evidence Repository: The NM_000215.4(JAK3):c.2625C>T (p.Leu875=) synonymous variant occurs at a high allele frequency with a filtering allele frequency based on the European non-Finnish population (upper bound of 95% CI of 1934/129188 observed alleles) is 0.01456 in gnomAD v2.1.1 which is above the SCID-VCEP threshold (>0.00447; BA1). 17 adult homozygous individuals were reported in gnomAD, BS2_Supporting (European non-Finnish n=10, South Asian n=3, European Finnish n=2, and Other n=2).The variant has been reported in one patient in the literature (Patient 17 in PMID:19203666). Patient 17 has T-B+NK- (0 CD3 T cells, 0.14x10^9 B cells/L, 0.01x10^9 NK cells/L) SCID (0.5pt) and absent IL-2–induced STAT5 phosphorylation (1pt). This combination is specific for T-B+ severe combined immunodeficiency due to JAK3 deficiency (Total 1.5pt; PP4 not considered due to high allele frequency). A confirmed deleterious γc or JAK3 variant was not identified in Patient 17, although a number of sequence variants were identified in his JAK3 gene (IVS13-30c>t/wt, c.2625C>T (L875L)/wt, IVS 20+32T>C/wt). An affected sibling of Patient 17 also carried these same variants, whereas an unaffected sibling did not (PP1 not considered due to high allele frequency). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive T-B+ SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: BA1, BS2_Supporting, and BP7. (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA214091/MONDO:0010938/121

Frequency

Genomes: 𝑓 0.0096 ( 11 hom., cov: 32)
Exomes 𝑓: 0.015 ( 193 hom. )

Consequence

JAK3
NM_000215.4 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:6

Conservation

PhyloP100: -0.0320

Publications

5 publications found
Variant links:
Genes affected
JAK3 (HGNC:6193): (Janus kinase 3) The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008]
JAK3 Gene-Disease associations (from GenCC):
  • T-B+ severe combined immunodeficiency due to JAK3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP7
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000215.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK3
NM_000215.4
MANE Select
c.2625C>Tp.Leu875Leu
synonymous
Exon 19 of 24NP_000206.2
JAK3
NM_001440439.1
c.2625C>Tp.Leu875Leu
synonymous
Exon 19 of 24NP_001427368.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK3
ENST00000458235.7
TSL:5 MANE Select
c.2625C>Tp.Leu875Leu
synonymous
Exon 19 of 24ENSP00000391676.1P52333-1
JAK3
ENST00000527670.5
TSL:1
c.2625C>Tp.Leu875Leu
synonymous
Exon 18 of 23ENSP00000432511.1P52333-1
JAK3
ENST00000534444.1
TSL:1
c.2625C>Tp.Leu875Leu
synonymous
Exon 19 of 23ENSP00000436421.1P52333-2

Frequencies

GnomAD3 genomes
AF:
0.00963
AC:
1466
AN:
152222
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00326
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00582
Gnomad ASJ
AF:
0.00548
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0130
Gnomad FIN
AF:
0.00997
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0153
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.0107
AC:
2700
AN:
251480
AF XY:
0.0116
show subpopulations
Gnomad AFR exome
AF:
0.00295
Gnomad AMR exome
AF:
0.00382
Gnomad ASJ exome
AF:
0.00437
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0121
Gnomad NFE exome
AF:
0.0152
Gnomad OTH exome
AF:
0.0117
GnomAD4 exome
AF:
0.0146
AC:
21407
AN:
1461872
Hom.:
193
Cov.:
33
AF XY:
0.0146
AC XY:
10598
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.00263
AC:
88
AN:
33480
American (AMR)
AF:
0.00409
AC:
183
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
113
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0143
AC:
1236
AN:
86258
European-Finnish (FIN)
AF:
0.0116
AC:
618
AN:
53420
Middle Eastern (MID)
AF:
0.0135
AC:
78
AN:
5768
European-Non Finnish (NFE)
AF:
0.0165
AC:
18378
AN:
1111990
Other (OTH)
AF:
0.0118
AC:
711
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1336
2672
4008
5344
6680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
694
1388
2082
2776
3470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00960
AC:
1463
AN:
152340
Hom.:
11
Cov.:
32
AF XY:
0.00925
AC XY:
689
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.00325
AC:
135
AN:
41584
American (AMR)
AF:
0.00582
AC:
89
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00548
AC:
19
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.0124
AC:
60
AN:
4830
European-Finnish (FIN)
AF:
0.00997
AC:
106
AN:
10630
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0153
AC:
1042
AN:
68028
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
70
139
209
278
348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0123
Hom.:
5
Bravo
AF:
0.00884
Asia WGS
AF:
0.00606
AC:
21
AN:
3478
EpiCase
AF:
0.0158
EpiControl
AF:
0.0161

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
T-B+ severe combined immunodeficiency due to JAK3 deficiency (3)
-
-
1
not provided (1)
-
-
1
not specified (1)
-
-
1
Severe combined immunodeficiency disease (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
6.3
DANN
Benign
0.62
PhyloP100
-0.032
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230589; hg19: chr19-17943383; API